Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

People with polycystic ovary syndrome often have low levels of vitamin D.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Essential oils from Curcuma species, like turmeric, have compounds that can fight inflammation, cancer, and bacteria, and can also stimulate hair regrowth in bald males.

Trichotillomania involves hair pulling and can be treated with therapy and medication.

Epidermal nevi are skin cell clusters linked to various syndromes.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Most Indian people with hair loss in the study lacked nutrients, especially iron.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Certain natural biostimulants can increase lettuce yield and improve its nutritional content.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

The document concludes that compulsive hair disorders, like trichotillomania, are complex and require careful diagnosis and treatment from both psychiatric and dermatological perspectives.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Skin cells show flexibility in healing wounds and forming tumors, with potential for treating hair disorders and chronic ulcers.

Marine microbes could be used in cosmetics for sun protection, skin care, and possibly preventing hair loss.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.